Should I Medicate My Child? The Decision No Parent Feels Ready For

There's a moment a lot of ADHD parents in Singapore know well. You're sitting across from a doctor, or scrolling a Facebook group at 1am, and the question isn't really "what medication" — it's something much heavier: am I doing the right thing for my child?

If you medicate, some part of you worries you're changing who they are, or taking the easy way out instead of "just" being a more patient parent. If you don't, another part of you worries you're letting them struggle — at school, with friends, with their own sense of themselves — when something might actually help.

There isn't a version of this decision that comes guilt-free. What we can do is make the trade-offs clearer, so the decision comes from information instead of fear.

First: the guilt you're feeling is common, and it isn't a sign you're doing this wrong

Almost every parent who considers medication goes through some version of this internal argument. It doesn't mean you're overreacting, and it doesn't mean the diagnosis is wrong. It means you're taking it seriously.

A few things worth sitting with before you decide anything:

• Medication doesn't change who your child is. For most children who respond well to it, what changes is their access to the self-control and focus that's already there — not their personality.
• "Trying it" isn't the same as "committing forever." Most families treat the first few months as a trial, with room to stop or adjust if it isn't the right fit.
• Choosing not to medicate is also a legitimate choice — especially alongside therapy, classroom accommodations, and routine-based support. There's rarely one "correct" answer that applies to every child.

Once you're weighing it, the real trade-offs start

If you're leaning toward trying medication, the guilt doesn't just disappear — it usually gets replaced by a new kind of headache: the logistics. Which route to go through, which medication, how often it needs to be taken, and what to actually watch for. Here's what each of those trade-offs looks like in practice.

Trade-off 1: Speed vs. cost — public and private care in Singapore

This is usually the first fork in the road, and it comes with its own emotional weight — needing help now versus what your family can sustain long-term.

Private psychiatrist:

• Consultation: $200–300 per session
• Medication: ~$400–450 a month
• Wait for first appointment: usually days
• Rough annual cost: ~$5,000+

Public hospital (subsidised):

• Consultation: $30–70 per session
• Medication: ~$9–60 for a 1–3 month supply
• Wait for first appointment: 3–6 months
• Rough annual cost: ~$700

Private care buys speed when you're in crisis mode and just want answers. Public care asks for patience, in exchange for a cost that's sustainable over the years many families end up needing support.

The path most parents don't realise is available: visit a SingHealth or NHG polyclinic and request a referral for an ADHD assessment, which leads to a public hospital (IMH, NUH, KTPH, or KKH for children) for diagnosis and subsidised medication. Bringing school reports or past assessments to that first visit won't skip the queue, but it helps the process move as smoothly as possible.

And if you've already started privately and the cost is becoming unsustainable, you're not locked in. Ask your private doctor for a referral memo or diagnostic report, bring past prescriptions and assessment records, and check with your chosen public hospital — some, like KTPH, accept private referrals directly, so you don't have to repeat the full diagnostic process from scratch.

Trade-off 2: Which medication — and what you're actually signing up for

This is where the headache of managing trade-offs gets very concrete. The medication names alone can be overwhelming, so here's what each one actually asks of your family — cost, how it works, and the honest downsides.

Ritalin (IR) — methylphenidate, immediate-release, stimulant. ~$9–60/month (public, subsidised) or ~$60–100/month (private).

• Pros: Widely available through public hospitals; lower cost when subsidised; dose can be adjusted flexibly through the day.
• Cons: Shorter duration means multiple daily doses; effects can wear off unevenly, sometimes causing a "crash."

Medikinet — methylphenidate, stimulant. ~$9–60/month (public, subsidised).

• Pros: Works similarly to Concerta in effect; significantly cheaper through the public system; available in both immediate and extended-release forms.
• Cons: Still a controlled stimulant with typical side effects; public route means a longer wait to start.

Concerta — methylphenidate, extended-release, stimulant. ~$200–250/month (private).

• Pros: Once-daily dosing is more convenient, especially for school days; smoother, more even release than IR formulations.
• Cons: Meaningfully more expensive privately; not typically the first option dispensed publicly.

Strattera — atomoxetine, non-stimulant. Cost varies — discuss with prescriber.

• Pros: Non-stimulant option for children who don't respond well to or can't tolerate stimulants; not a controlled substance.
• Cons: Takes longer (often weeks) to show full effect; generally considered only after stimulants have been tried.

Adderall — amphetamine, stimulant. Not approved for use in Singapore. Avoid sellers on Telegram or other unofficial channels — beyond the legal risk, there's no way to verify what you're actually receiving.

There's no "best" medication in the abstract — only what fits your child's response and your family's daily rhythm. Many families need to try more than one before finding the right fit, and that process of adjustment is normal, not a sign that something's gone wrong.

Trade-off 3: How often it's taken, and what to actually watch for

Cost isn't the only thing weighing on you day-to-day — how often your child needs a dose, and what to watch for once they start, matters just as much once school hours, meals, and sleep are factored in.

Ritalin (IR) — typically taken 2–3 times a day.

• Common side effects: Reduced appetite, difficulty falling asleep, mild stomachache, headache, irritability as each dose wears off.
• What to take note of: May need a midday dose administered at school — check your school's policy. Watch for a "rebound" effect as each dose wears off.

Medikinet — once daily (extended-release) or split doses (IR form).

• Common side effects: Similar to Ritalin — appetite suppression, sleep difficulty, mild mood changes.
• What to take note of: Extended-release avoids a school-time dose, but effects may taper unevenly by late afternoon for some children.

Concerta — once daily, typically taken in the morning.

• Common side effects: Reduced appetite (often noticeable at lunch), insomnia if taken late, mild increase in heart rate, occasional headache.
• What to take note of: Convenient once-daily dosing, but side effects — especially appetite suppression — can last longer through the day than IR formulations.

Strattera — once or twice daily, taken consistently.

• Common side effects: Nausea, fatigue or drowsiness (especially early weeks), decreased appetite, mood changes in some children.
• What to take note of: Builds up gradually over days to weeks — won't work if only given on school days. Should not be stopped abruptly without medical advice.

The core trade-off: shorter-acting medications give you and your doctor more flexibility to adjust or skip a dose on a given day, but ask more of your daily routine — coordinating with school, managing more frequent "wearing off" moments. Longer-acting medications are easier day-to-day, but once a side effect shows up, it tends to run for longer, with less room to course-correct mid-day.

A few things worth flagging to your doctor regardless of which medication your child ends up on:

• Appetite and growth — stimulants commonly reduce appetite, especially at lunch. A bigger breakfast and dinner, plus periodic growth monitoring, is a common adjustment.
• Sleep — most stimulants should be avoided too late in the day, even in children who don't otherwise report feeling "wired."
• Mood and personality changes — a child who seems unusually flat, withdrawn, or irritable is worth a follow-up conversation. That usually means the dose or medication needs adjusting, not that your child should "push through" it.
• It's rarely right on the first try — many families go through some trial and adjustment in the first few months. This is normal, and doesn't mean the diagnosis was wrong or that medication isn't working for your child.

What can help with the cost, if that's part of your calculation

• CHAS and MediSave can offset some mental health-related costs, though coverage is limited — worth checking your specific eligibility.
• Methylphenidate is on the MOH Subsidised Drug List, which is a large part of why the public route is so much cheaper.
• Once your child's dosage has stabilised, ask about being prescribed 2–3 months' worth of medication at a time instead of monthly, to reduce the number of paid consultation visits over a year.
• CBT and ADHD coaching are available through IMH at subsidised rates, and can complement or, for some families, substitute for medication — worth raising with your care team as part of the bigger picture, not just an afterthought.

The bottom line

There's no universally "right" choice here — only the choice that fits your child's needs and your family's capacity, at this point in time. Choosing to medicate doesn't mean you've given up on other approaches, and choosing not to doesn't mean you're not taking the diagnosis seriously.

If you're in the middle of deciding, it can help to treat it as a trial with a review point — say, 8 to 12 weeks — rather than a permanent decision made in one sitting. That reframing alone takes some of the weight off a choice that was never going to feel entirely comfortable either way.

This article is based on structured research and shared parent experience, and is intended as general guidance, not medical advice. Every child responds differently — always make medication decisions in consultation with your child's prescribing doctor.

‍